Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Biology and biochemistry of platelet-activating factor.

× No keyword cloud information.

145 in total

1. THE ROLE OF MICRO-EMBOLISM IN THE PRODUCTION OF IRREVERSIBLE SHOCK.

Authors: H J ROBB
Journal: Ann Surg Date: 1963-10 Impact factor: 12.969

2. Effects on the pulmonary circulation of suddenly induced intravascular aggregation of blood platelets.

Authors: G Bo; J Hognestad
Journal: Acta Physiol Scand Date: 1972-08

3. One, two, three or more pathways for platelet aggregation.

Authors: B B Vargaftig; M Chignard; J P Le Couedic; J Benveniste
Journal: Acta Med Scand Suppl Date: 1980

4. Stimulation of human neutrophil degranulation with 1-O-octadecyl-2-O-acetyl-SN-glyceryl-3-phosphorylcholine: modulation by inhibitors of arachidonic acid metabolism.

Authors: R J Smith; B J Bowman
Journal: Biochem Biophys Res Commun Date: 1982-02-26 Impact factor: 3.575

5. Release of 1-O-alkylglyceryl 3-phosphorylcholine, O-deacetyl platelet-activating factor, from leukocytes: chemical ionization mass spectrometry of phospholipids.

Authors: J Polonsky; M Tencé; P Varenne; B C Das; J Lunel; J Benveniste
Journal: Proc Natl Acad Sci U S A Date: 1980-12 Impact factor: 11.205

6. Production and release of platelet-activating factor (PAF); dissociation from degranulation and superoxide production in the human neutrophil.

Authors: S J Betz; P M Henson
Journal: J Immunol Date: 1980-12 Impact factor: 5.422

7. Ether lipid content and fatty acid distribution in rabbit polymorphonuclear neutrophil phospholipids.

Authors: H W Mueller; J T O'Flaherty; R L Wykle
Journal: Lipids Date: 1982-02 Impact factor: 1.880

8. Platelet-activating factor effects on pulmonary ultrastructure in rabbits.

Authors: J C Lewis; J T O'Flaherty; C E McCall; R L Wykle; M G Bond
Journal: Exp Mol Pathol Date: 1983-02 Impact factor: 3.362

9. Release of platelet-activating factor and histamine. I. Effect of immune complexes, complement and neutrophils on human and rabbit mastocytes and basophils.

Authors: G Camussi; J M Mencia-Huerta; J Benveniste
Journal: Immunology Date: 1977-10 Impact factor: 7.397

10. Studies on the mechanism of the Shwartzman phenomenon; certain factors involved in the production of the local hemorrhagic necrosis.

Authors: C A STETSON
Journal: J Exp Med Date: 1951-05 Impact factor: 14.307

18 in total

1. Lyso platelet activating factor (LysoPAF) and its enantiomer. Total synthesis and carbon-13 NMR spectroscopy.

Authors: M P Murari; R Murari; S Parthasarathy; C A Guy; V V Kumar; B Malewicz; W J Baumann
Journal: Lipids Date: 1990-10 Impact factor: 1.880

2. Effect of Staphylococcus aureus delta-toxin on human granulocyte functions and platelet-activating-factor metabolism.

Authors: S Kasimir; W Schönfeld; J E Alouf; W König
Journal: Infect Immun Date: 1990-06 Impact factor: 3.441

3. Identification of a specific region of low molecular weight phospholipases A2 (residues 21-40) as a potential target for structure-based design of inhibitors of these enzymes.

Authors: E Cordella-Miele; L Miele; A B Mukherjee
Journal: Proc Natl Acad Sci U S A Date: 1993-11-01 Impact factor: 11.205

4. Platelet-activating factor (PAF) in allergic diseases: inhibitory effects of anti-allergic drugs, ketotifen and three kampo medicines on PAF production.

Authors: T Nakamura; M Kuriyama; K Ishihara; Y Matsumura; T Miyamoto
Journal: Lipids Date: 1991-12 Impact factor: 1.880

Biology and biochemistry of platelet-activating factor.